Oops! This is member-only content.
Please login, sign up for a full membership, or sign up for a free 30-day trial membership to access this content.
FDA News: Addressing Naloxone Availability for Residents With Opioid Use Disorder (9/22)
The FDA published the FDA Voices: “FDA Issues New Guidance to Help Facilitate Availability of Naloxone to Prevent Opioid Overdoses and Reduce Death,” by Marta Sokolowska, Ph.D., Deputy Center Director for Substance Use and Behavioral...